Underrecognition of Fecal Incontinence in Systemic Sclerosis: Discrepancies Between the Rome IV Diagnostic Questionnaires and the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 Questionnaire
Abstract
Gastrointestinal (GI) involvement in systemic sclerosis (SSc) is common, with up to 87% of people affected.1 Of all SSc manifestations, GI disease has the greatest impact on quality of life.2
Fields of Study & Subjects
Systemic Sclerosis and Related Diseases
Dysphagia Assessment and Management
Gastrointestinal motility and disorders
Publication details
- Journal / source
- The Journal of Rheumatology
- Publisher
- The Journal of Rheumatology
- Volume
- 53
- Issue
- 6
- Pages
- 704–705
- Publication date
- 15 February 2026
- Language
- EN